KEAP1 and esophageal squamous cell carcinoma: <b>Conclusions</b>: These findings show that PYR functionally restores KEAP1-mediated NRF2 degradation of select NRF2<sup>Mut</sup> through a glue-like effect and overcomes therapy resistance in ESCC.